Pulse Biosciences: Clinical Progress – Approval Now Approaches

Pulse Biosciences is a US medical technology company developing innovative methods for targeted tissue ablation. The focus is on its proprietary technology that operates with very short electrical pulses and is intended for applications in cardiology and thyroid diseases, among others. The company is still in an early commercialization phase and primarily invests in clinical trials, approvals, and the expansion of its product platform. For investors, the technology offers significant growth potential; however, risks remain relatively high due to...